IKS014 in Advanced Solid Tumors That Express HER2
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Gastric Cancer|Gastroesophageal-junction Cancer
Interventions: DRUG: IKS014
Sponsor: Iksuda Therapeutics Ltd.